IQVIA Holdings Inc. is a premier global provider of sophisticated analytical insights, advanced technology solutions, and comprehensive clinical research services, catering to the life sciences industry across the Americas, Europe, Africa, and Asia-Pacific. The company's operations are structured into three key divisions: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment provides a suite of cloud-native applications, complete with implementation services, and offers real-world data solutions designed to empower life sciences and healthcare providers in generating and disseminating evidence crucial for informed decision-making and improving patient outcomes. This division also delivers strategic and operational consulting, including advanced analytics support and outsourcing of commercial processes. Furthermore, it supplies country-level performance metrics detailing pharmaceutical sales, prescribing trends, medical treatments, and promotional activities across diverse channels like retail, hospital, and mail order, with data granularity extending to regional, postal code, and individual prescriber levels. Focusing on clinical trials, the Research & Development Solutions segment offers project management, clinical monitoring, broader clinical trial support, virtual trial capabilities, and strategic planning and design services. It also manages an extensive network of laboratory services, encompassing central, genomic, bioanalytical, ADME, discovery, vaccine, and biomarker analyses. The Contract Sales & Medical Solutions segment is responsible for engaging healthcare professionals and patients, alongside providing scientific strategy and medical affairs support. IQVIA's diverse clientele includes pharmaceutical, biotechnology, medical device and diagnostic, and consumer health companies. The company maintains a strategic collaboration with HealthCore, Inc. Founded in 1982, the firm was formerly known as Quintiles IMS Holdings, Inc. before rebranding as IQVIA Holdings Inc. in November 2017. Its headquarters are located in Durham, North Carolina.
The current price of IQV is $178.25 USD — it has decreased by -1.77% in the past 24 hours. Watch IQVIA stock price performance more closely on the chart.
What is IQVIA stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange IQVIA stocks are traded under the ticker IQV.
Is IQVIA stock price growing?▼
IQV stock has fallen by -3.12% compared to the previous week, the month change is a +5.22% rise, over the last year IQVIA has showed a +13.42% increase.
What is IQVIA market cap?▼
Today IQVIA has the market capitalization of 30.25B
When is the next IQVIA earnings date?▼
IQVIA is going to release the next earnings report on July 28, 2026.
What were IQVIA earnings last quarter?▼
IQV earnings for the last quarter are 2.9 USD per share, whereas the estimation was 2.82 USD resulting in a +2.97% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is IQVIA revenue for the last year?▼
IQVIA revenue for the last year amounts to 32.62B USD.
What is IQVIA net income for the last year?▼
IQV net income for the last year is 2.72B USD.
How many employees does IQVIA have?▼
As of June 15, 2026, the company has 89,000 employees.